Don't Miss Out

Subscribe to OCA's News & Alerts.

Bayer Set To Rethink Selling of Glyphosate to US Gardeners After Loss of $2 Billion Future Cancer Claims Deal

Bayer’s share price crashed over 4% on Thursday after Judge Vince Chhabria of the U.S. District Court for the Northern District of California threw out their attempted $ 2 Bilion deal to settle future cancer claims against their top selling glyphosate-based herbicide, Roundup.

Bayer reacted by stating Thursday: “While the Company will remain in the residential lawn and garden market, it will immediately engage with partners to discuss the future of glyphosate-based products in the U.S. residential market, as the overwhelming majority of claimants in the Roundup™ litigation allege that they used Roundup™ Lawn and Garden products.”

In a brief order that addresses what the judge called only “the most glaring flaws” of the deal, Chhabria turned aside the complicated agreement, the second time he’s shot it down, Bloomberg reported Thursday. The rejected settlement is part of a broader $11.6 billion agreement to resolve Roundup lawsuits in the U.S. from about 125,000 consumers and farmers.